Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 2 |
GO:0005849 | mRNA cleavage factor complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:0005634 | nucleus | 5 | 8 |
GO:0043226 | organelle | 2 | 8 |
GO:0043227 | membrane-bounded organelle | 3 | 8 |
GO:0043229 | intracellular organelle | 3 | 8 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 8 |
Related structures:
AlphaFold database: Q4QJI4
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006378 | mRNA polyadenylation | 7 | 2 |
GO:0006379 | mRNA cleavage | 7 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006397 | mRNA processing | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0031123 | RNA 3'-end processing | 7 | 2 |
GO:0031124 | mRNA 3'-end processing | 8 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043631 | RNA polyadenylation | 6 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 2 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 2 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 2 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 10 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043169 | cation binding | 3 | 10 |
GO:0046872 | metal ion binding | 4 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 21 | 25 | PF00656 | 0.656 |
CLV_C14_Caspase3-7 | 336 | 340 | PF00656 | 0.697 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.655 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.318 |
CLV_PCSK_PC1ET2_1 | 350 | 352 | PF00082 | 0.632 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.318 |
CLV_PCSK_PC7_1 | 346 | 352 | PF00082 | 0.662 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.575 |
DOC_CKS1_1 | 289 | 294 | PF01111 | 0.666 |
DOC_MAPK_MEF2A_6 | 43 | 50 | PF00069 | 0.515 |
DOC_PP4_FxxP_1 | 345 | 348 | PF00568 | 0.668 |
DOC_USP7_MATH_1 | 267 | 271 | PF00917 | 0.614 |
DOC_WW_Pin1_4 | 288 | 293 | PF00397 | 0.734 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.498 |
LIG_BIR_III_2 | 24 | 28 | PF00653 | 0.660 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.567 |
LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.330 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.611 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.653 |
LIG_LIR_Apic_2 | 343 | 348 | PF02991 | 0.725 |
LIG_LIR_Nem_3 | 83 | 88 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.293 |
LIG_MLH1_MIPbox_1 | 82 | 86 | PF16413 | 0.330 |
LIG_Pex14_2 | 86 | 90 | PF04695 | 0.293 |
LIG_PTB_Apo_2 | 203 | 210 | PF02174 | 0.513 |
LIG_PTB_Apo_2 | 84 | 91 | PF02174 | 0.293 |
LIG_PTB_Phospho_1 | 203 | 209 | PF10480 | 0.528 |
LIG_SH2_CRK | 183 | 187 | PF00017 | 0.777 |
LIG_SH2_CRK | 290 | 294 | PF00017 | 0.733 |
LIG_SH2_GRB2like | 85 | 88 | PF00017 | 0.293 |
LIG_SH2_NCK_1 | 290 | 294 | PF00017 | 0.663 |
LIG_SH2_SRC | 65 | 68 | PF00017 | 0.318 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.384 |
LIG_SH2_STAT3 | 171 | 174 | PF00017 | 0.708 |
LIG_SH2_STAT3 | 360 | 363 | PF00017 | 0.705 |
LIG_SH2_STAT5 | 290 | 293 | PF00017 | 0.665 |
LIG_SH2_STAT5 | 312 | 315 | PF00017 | 0.714 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.295 |
LIG_SH3_1 | 183 | 189 | PF00018 | 0.685 |
LIG_SH3_1 | 289 | 295 | PF00018 | 0.668 |
LIG_SH3_1 | 346 | 352 | PF00018 | 0.692 |
LIG_SH3_2 | 304 | 309 | PF14604 | 0.705 |
LIG_SH3_3 | 183 | 189 | PF00018 | 0.685 |
LIG_SH3_3 | 242 | 248 | PF00018 | 0.662 |
LIG_SH3_3 | 289 | 295 | PF00018 | 0.743 |
LIG_SH3_3 | 301 | 307 | PF00018 | 0.640 |
LIG_SH3_3 | 346 | 352 | PF00018 | 0.704 |
LIG_SH3_3 | 356 | 362 | PF00018 | 0.646 |
LIG_SUMO_SIM_anti_2 | 66 | 71 | PF11976 | 0.384 |
LIG_TRAF2_1 | 100 | 103 | PF00917 | 0.384 |
LIG_TRAF2_1 | 131 | 134 | PF00917 | 0.658 |
LIG_WRC_WIRS_1 | 314 | 319 | PF05994 | 0.520 |
MOD_CDC14_SPxK_1 | 306 | 309 | PF00782 | 0.523 |
MOD_CDK_SPxK_1 | 303 | 309 | PF00069 | 0.522 |
MOD_CK1_1 | 338 | 344 | PF00069 | 0.817 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.629 |
MOD_GlcNHglycan | 269 | 272 | PF01048 | 0.792 |
MOD_GlcNHglycan | 329 | 332 | PF01048 | 0.728 |
MOD_GlcNHglycan | 342 | 345 | PF01048 | 0.746 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.631 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.643 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.628 |
MOD_N-GLC_2 | 226 | 228 | PF02516 | 0.222 |
MOD_NEK2_1 | 327 | 332 | PF00069 | 0.663 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.537 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.295 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.515 |
MOD_ProDKin_1 | 288 | 294 | PF00069 | 0.731 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.501 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.293 |
TRG_NES_CRM1_1 | 37 | 51 | PF08389 | 0.601 |
TRG_NLS_MonoCore_2 | 349 | 354 | PF00514 | 0.693 |
TRG_NLS_MonoExtC_3 | 349 | 355 | PF00514 | 0.716 |
TRG_NLS_MonoExtN_4 | 348 | 354 | PF00514 | 0.664 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5N7 | Leptomonas seymouri | 54% | 100% |
A0A0S4JNN9 | Bodo saltans | 33% | 100% |
A0A3S5H5G4 | Leishmania donovani | 89% | 100% |
A4H465 | Leishmania braziliensis | 80% | 100% |
A4HSD3 | Leishmania infantum | 89% | 100% |
C9ZPW6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AKC3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 98% |
V5BAD2 | Trypanosoma cruzi | 38% | 100% |